PRAZOSIN HCL
ALPHA-BLOCKERS · HYPERTENSION
APHENA PHARMA S
Drug class
Alpha-Blockers
Alpha-blockers, formally designated as alpha-adrenergic receptor antagonists, are a class of pharmacologic agents that selectively or nonselectively inhibit the action of norepinephrine and epinephrine at alpha-adrenergic receptors. Read more about Alpha-Blockers
184 drugs in this class 89 manufacturers
Drugs in Alpha-Blockers
TAMSULOSIN HCL
ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
APHENA PHARMA S
TERAZOSIN HCL
ALPHA-BLOCKERS · HYPERTENSION ·+1
APHENA PHARMA S
LABETALOL HCL
ALPHA-BLOCKERS · HYPERTENSION
EYWA PHARMA INC
LABETALOL HCL
ALPHA-BLOCKERS · HYPERTENSION
FOSUN PHARMA US
LABETALOL HCL
ALPHA-BLOCKERS · HYPERTENSION
CIVICA, INC.
LABETALOL HCL
ALPHA-BLOCKERS · HYPERTENSION
ADVAGEN PHARMA
PRAZOSIN HCL
ALPHA-BLOCKERS · HYPERTENSION
EXELAN PHARMACE
TAMSULOSIN HCL
ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
EXELAN PHARMACE
Filter & compare in the drug finder →
Opens the drug finder with Alpha-Blockers preselected. Add indication or manufacturer filters there.
Alpha-blockers, formally designated as alpha-adrenergic receptor antagonists, are a class of pharmacologic agents that selectively or nonselectively inhibit the action of norepinephrine and epinephrine at alpha-adrenergic receptors.
By blocking these receptors on vascular and nonvascular smooth muscle, they promote vasodilation and decrease smooth muscle tone.
Clinically, these medications are primarily utilized to improve urinary flow in benign prostatic hyperplasia, reduce peripheral vascular resistance in essential hypertension, and control blood pressure spikes associated with pheochromocytoma.
-
nih.gov
Alpha-blockers, formally designated as alpha-adrenergic receptor antagonists, are a class of pharmacologic agents that selectively or nonselectively inhibit the action of norepinephrine and epinephrine at alpha-adrenergic receptors Clinically, these medications are primarily utilized to improve urinary flow in benign prostatic hyperplasia, reduce peripheral vascular resistance in essential hypertension, and control blood pressure spikes associated with pheochromocytoma
-
nih.gov
By blocking these receptors on vascular and nonvascular smooth muscle, they promote vasodilation and decrease smooth muscle tone
-
nih.gov
By blocking these receptors on vascular and nonvascular smooth muscle, they promote vasodilation and decrease smooth muscle tone
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.